SK12872000A3 - Spôsob a medziprodukty na výrobu inhibítorov 5-lipoxygenázy s rôznymi heterocyklickými systémami - Google Patents
Spôsob a medziprodukty na výrobu inhibítorov 5-lipoxygenázy s rôznymi heterocyklickými systémami Download PDFInfo
- Publication number
- SK12872000A3 SK12872000A3 SK1287-2000A SK12872000A SK12872000A3 SK 12872000 A3 SK12872000 A3 SK 12872000A3 SK 12872000 A SK12872000 A SK 12872000A SK 12872000 A3 SK12872000 A3 SK 12872000A3
- Authority
- SK
- Slovakia
- Prior art keywords
- formula
- compound
- group
- reaction mixture
- palladium
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Rheumatology (AREA)
- Hospice & Palliative Care (AREA)
- Cardiology (AREA)
- Pulmonology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Pyrane Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US15161599P | 1999-08-31 | 1999-08-31 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SK12872000A3 true SK12872000A3 (sk) | 2001-11-06 |
Family
ID=22539529
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SK1287-2000A SK12872000A3 (sk) | 1999-08-31 | 2000-08-25 | Spôsob a medziprodukty na výrobu inhibítorov 5-lipoxygenázy s rôznymi heterocyklickými systémami |
Country Status (33)
| Country | Link |
|---|---|
| US (1) | US6346624B1 (pt) |
| EP (1) | EP1081143A1 (pt) |
| JP (1) | JP2001106682A (pt) |
| KR (1) | KR20010050256A (pt) |
| CN (1) | CN1286250A (pt) |
| AP (1) | AP2000001910A0 (pt) |
| AU (1) | AU5360300A (pt) |
| BG (1) | BG104731A (pt) |
| BR (1) | BR0003945A (pt) |
| CA (1) | CA2317097A1 (pt) |
| CZ (1) | CZ20003158A3 (pt) |
| EA (1) | EA200000801A1 (pt) |
| EE (1) | EE200000512A (pt) |
| GT (1) | GT200000142A (pt) |
| HR (1) | HRP20000564A2 (pt) |
| HU (1) | HUP0003439A3 (pt) |
| ID (1) | ID27129A (pt) |
| IL (1) | IL138087A0 (pt) |
| IS (1) | IS5603A (pt) |
| MA (1) | MA26751A1 (pt) |
| NO (1) | NO20004313L (pt) |
| NZ (1) | NZ506632A (pt) |
| OA (1) | OA11452A (pt) |
| PA (1) | PA8499701A1 (pt) |
| PE (1) | PE20010520A1 (pt) |
| PL (1) | PL342281A1 (pt) |
| SG (1) | SG87146A1 (pt) |
| SK (1) | SK12872000A3 (pt) |
| SV (1) | SV2002000159A (pt) |
| TN (1) | TNSN00177A1 (pt) |
| TR (1) | TR200002529A2 (pt) |
| UY (1) | UY26314A1 (pt) |
| ZA (1) | ZA200004435B (pt) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6669042B1 (en) * | 2002-09-30 | 2003-12-30 | Hewlett-Packard Development Company, L.P. | Integrated positioning and locking device |
| EP1834953A1 (en) * | 2006-03-14 | 2007-09-19 | Ranbaxy Laboratories Limited | Tetrahydropyrane derivatives as 5-lipoxygenase inhibitors |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5883106A (en) * | 1994-10-18 | 1999-03-16 | Pfizer Inc. | 5-lipoxygenase inhibitors |
| SK281577B6 (sk) | 1994-10-18 | 2001-05-10 | Pfizer Inc. | Heterocyklické zlúčeniny a farmaceutický prostriedok na ich báze |
| US6063928A (en) * | 1994-10-18 | 2000-05-16 | Pfizer Inc | 5-lipoxygenase inhibitors |
| US6239285B1 (en) * | 1998-02-06 | 2001-05-29 | Pfizer Inc | Process for making 5-lipoxygenase inhibitors having varied heterocyclic ring systems |
-
2000
- 2000-06-29 US US09/607,011 patent/US6346624B1/en not_active Expired - Fee Related
- 2000-08-01 SG SG200004341A patent/SG87146A1/en unknown
- 2000-08-10 PA PA20008499701A patent/PA8499701A1/es unknown
- 2000-08-16 EP EP00307014A patent/EP1081143A1/en not_active Withdrawn
- 2000-08-18 OA OA1200000225A patent/OA11452A/en unknown
- 2000-08-24 AU AU53603/00A patent/AU5360300A/en not_active Abandoned
- 2000-08-24 IL IL13808700A patent/IL138087A0/xx unknown
- 2000-08-25 IS IS5603A patent/IS5603A/is unknown
- 2000-08-25 SK SK1287-2000A patent/SK12872000A3/sk unknown
- 2000-08-28 ID IDP20000711A patent/ID27129A/id unknown
- 2000-08-28 GT GT200000142A patent/GT200000142A/es unknown
- 2000-08-28 UY UY26314A patent/UY26314A1/es not_active Application Discontinuation
- 2000-08-28 ZA ZA200004435A patent/ZA200004435B/xx unknown
- 2000-08-29 CA CA002317097A patent/CA2317097A1/en not_active Abandoned
- 2000-08-29 JP JP2000259063A patent/JP2001106682A/ja active Pending
- 2000-08-29 BG BG104731A patent/BG104731A/xx unknown
- 2000-08-29 PE PE2000000885A patent/PE20010520A1/es not_active Application Discontinuation
- 2000-08-30 HU HU0003439A patent/HUP0003439A3/hu unknown
- 2000-08-30 NZ NZ506632A patent/NZ506632A/en unknown
- 2000-08-30 CZ CZ20003158A patent/CZ20003158A3/cs unknown
- 2000-08-30 EA EA200000801A patent/EA200000801A1/ru unknown
- 2000-08-30 TN TNTNSN00177A patent/TNSN00177A1/fr unknown
- 2000-08-30 HR HR20000564A patent/HRP20000564A2/hr not_active Application Discontinuation
- 2000-08-30 CN CN00126408A patent/CN1286250A/zh active Pending
- 2000-08-30 MA MA26054A patent/MA26751A1/fr unknown
- 2000-08-30 NO NO20004313A patent/NO20004313L/no not_active Application Discontinuation
- 2000-08-30 KR KR1020000050608A patent/KR20010050256A/ko active IP Right Grant
- 2000-08-30 SV SV2000000159A patent/SV2002000159A/es unknown
- 2000-08-31 BR BR0003945-4A patent/BR0003945A/pt not_active IP Right Cessation
- 2000-08-31 TR TR2000/02529A patent/TR200002529A2/xx unknown
- 2000-08-31 EE EEP200000512A patent/EE200000512A/xx unknown
- 2000-08-31 AP APAP/P/2000/001910A patent/AP2000001910A0/en unknown
- 2000-08-31 PL PL00342281A patent/PL342281A1/xx not_active Application Discontinuation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0246713B1 (en) | Intermediates for the production of nitrogen-containing substituted heterocyclic compounds | |
| ZA200605471B (en) | Process for the preparation of pyridine derivatives | |
| SK694A3 (en) | Process for the preparation of diphenyl derivatives | |
| NO164295B (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive fluorerte benzyltriazolforbindelser. | |
| KR100720220B1 (ko) | 치환 아닐린 화합물의 제조방법 | |
| SK12872000A3 (sk) | Spôsob a medziprodukty na výrobu inhibítorov 5-lipoxygenázy s rôznymi heterocyklickými systémami | |
| EP0015615A1 (en) | Phenyl piperazine derivatives, their preparation and antiagressive medicines containing them | |
| US6344563B1 (en) | Process for making 5-lipoxygenase inhibitors having varied heterocyclic ring systems | |
| JP2771994B2 (ja) | プロペン酸誘導体の製造法 | |
| US6239285B1 (en) | Process for making 5-lipoxygenase inhibitors having varied heterocyclic ring systems | |
| SK12862000A3 (sk) | Spôsob výroby inhibítorov 5-lipoxygenázy s rôznymi heterocyklickými systémami | |
| JPH0468309B2 (pt) | ||
| CN106220554B (zh) | 一种芳基吡啶及其衍生物的制备方法 | |
| EP0162359A2 (en) | A process for preparing imidazole derivatives | |
| CA1180018A (en) | Halomethyltriazoles | |
| US4450308A (en) | Process for the preparation of trifluoromethylphenyl oxyphenyl ether compounds | |
| KR100311949B1 (ko) | 1-[(사이클로펜트-3-엔-1-일)메틸]-5-에틸-6-(3,5-다이메틸벤조일)-2,4-피리미딘다이온의제조방법 | |
| GB2186571A (en) | Imidazol-1-yl-carboxylic acid ester derivatives, processes for preparing same and fungicidal compositions comprising the derivative as active component | |
| CN116724025A (zh) | 唑衍生物的制造方法 | |
| JPH0359888B2 (pt) | ||
| SK4202000A3 (en) | Process of making 3-aryloxy-4-aryl furan-2-ones useful as inhibitors of cox-2 | |
| CZ20003507A3 (cs) | Způsob přípravy meziproduktů | |
| JPH0330594B2 (pt) |